Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
59.2M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
6.44M
-
Shares change
-
+6.44M
-
Total reported value, excl. options
-
$116M
-
Value change
-
+$116M
-
Number of buys
-
27
-
Price
-
$17.95
Significant Holders of Adagene Inc. - Ordinary Shares (ADAG) as of Q1 2021
27 filings reported holding ADAG - Adagene Inc. - Ordinary Shares as of Q1 2021.
Adagene Inc. - Ordinary Shares (ADAG) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.44M shares
of 59.2M outstanding shares and own 10.87% of the company stock.
Largest 10 shareholders include Capital International Investors (923K shares), MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC (839K shares), Artal Group S.A. (800K shares), CREDIT SUISSE AG/ (606K shares), Strategic Vision Investment Ltd (459K shares), MORGAN STANLEY (455K shares), Allianz Asset Management GmbH (439K shares), CAPITAL INTERNATIONAL INC (383K shares), Hudson Bay Capital Management LP (332K shares), and ORBIMED ADVISORS LLC (275K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.